Relationship between glomerulomegaly and clinicopathologic findings in IgA nephropathy

Clinical Nephrology

Volumn 78, Issue 6, 2012, Pages 470-477

  Jang, Won Seok ^a   Jeong, Kyung Hwan ^a   Moon, Joo Young ^a   Lee, Sang Ho ^a   Cho, Joo Hee ^a   Lee, Tae Won ^a   Park, Yong Koo ^a   Cho, Byoung Soo ^a   Ihm, Chun Gyoo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Glomerular surface area; IgA nephropathy; pathology; Renal outcome

Indexed keywords

ADOLESCENT; ADULT; AGE; ANALYZER; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBROSING ALVEOLITIS; GLOMERULAR STRUCTURE; GLOMERULAR SURFACE AREA; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MALE; SCHOOL CHILD; SURFACE PROPERTY; SYSTOLIC BLOOD PRESSURE;

ADULT; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED;

EID: 84871544705     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107614     Document Type: Article

References (43)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987; 64: 709-727.
2. Bogenschütz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Gärtner HV. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol. 1990; 10: 137-147.
3. Johnston PA, Brown JS, Braumholtz DA, Davison AM. Clinico-pathological correlations and longterm follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med. 1992; 84: 619-627.
4. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997; 8: 199-207.
5. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol. 2005; 18: 503-512.
6. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24: 179-196.
7. Choi S, Lee D, Jeong KH, Moon JY, Lee SH, Lee TW, Ihm CG. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers. Clin Nephrol. 2009; 72: 353-359.
8. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002; 17: 1197-1203.
9. Walsh M, Sar A, Lee D, Yilmaz S, Benediktsson H, Manns B, Hemmelgarn B. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol. 2010; 5: 425-430.
10. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis. 1991; 18: 12-19.
11. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997; 29: 829-842.
12. Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. IgA nephropathy: prognostic significance of proteinuria and histological alterations. Nephron. 1983; 34: 146-153.
13. Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, Katz AI. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982; 13: 314-322.
14. Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007; 49: 763-775.
15. Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant. 2005; 20: 342-348.
16. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988; 1: 335-347
17. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996; 49: 1774-1777.
18. Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl. 1997; 63: S124-S127.
19. Fogo A, Ichikawa I. Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis. 1991; 17: 666-669.
20. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol. 1985; 249: F324-F337.
21. Shimamura T, Morrison AB. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol. 1975; 79: 95-106.
22. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR. Long-term follow-up after partial removal of a solitary kidney. N Engl J Med. 1991; 325: 1058-1062.
23. Puelles VG, Hoy WE, Hughson MD, Diouf B, Douglas-Denton RN, Bertram JF. Glomerular number and size variability and risk for kidney disease. Curr Opin Nephrol Hypertens. 2011; 20: 7-15.
24. Abdi R, Slakey D, Kittur D, Racusen LC. Heterogeneity of glomerular size in normal donor kidneys: impact of race. Am J Kidney Dis. 1998; 32: 43-46.
25. Schmidt K, Pesce C, Liu Q, Nelson RG, Bennett PH, Karnitschnig H, Striker LJ, Striker GE. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol. 1992; 3: 229-235.
26. Young RJ, Hoy WE, Kincaid-Smith P, Seymour AE, Bertram JF. Glomerular size and glomerulosclerosis in Australian aborigines. Am J Kidney Dis. 2000; 36: 481-489.
27. Tsuboi N, Kawamura T, Ishii T, Utsunomiya Y, Hosoya T. Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy. Nephrol Dial Transplant. 2009; 24: 892-899.
28. Tóth T, Takebayashi S. Glomerular hypertrophy as a prognostic marker in childhood IgA nephropathy. Nephron. 1998; 80: 285-291.
29. Kataoka H, Ohara M, Honda K, Mochizuki T, Nitta K. Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy. Nephrol Dial Transplant. 2011; 26: 3937-3943.
30. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993; 44: 411-422
31. Oberholzer M, Torhorst J, Perret E, Mihatsch MJ. Minimum sample size of kidney biopsies for semiquantitative and quantitative evaluation. Nephron. 1983; 34: 192-195.
32. Kanetsuna Y, Hirano K, Nagata M, Gannon MA, Takahashi K, Harris RC, Breyer MD, Takahashi T. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes. Am J Physiol Renal Physiol. 2006; 291: F1315-F1322.
33. Adamczak M, Gross ML, Amann K, Ritz E. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol. 2004; 15: 3063-3072.
34. Nenov VD, Taal MW, Sakharova OV, Brenner BM. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens. 2000; 9: 85-97.
35. Amann K, Irzyniec T, Mall G, Ritz E. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis. J Hypertens. 1993; 11: 969-975.
36. Samuel T, Hoy WE, Douglas-Denton R, Hughson MD, Bertram JF. Determinants of glomerular volume in different cortical zones of the human kidney. J Am Soc Nephrol. 2005; 16: 3102-3109.
37. Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, Bochud M. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis. 2010; 56: 303-312.
38. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008; 73: 19-33.
39. Tanaka M, Yamada S, Iwasaki Y, Sugishita T, Yonemoto S, Tsukamoto T, Fukui S, Takasu K, Muso E. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients. Nephron Clin Pract. 2009; 112: c71-c78.
40. Goumenos DS, Kawar B, El Nahas M, Conti S, Wagner B, Spyropoulos C, Vlachojannis JG, Benigni A, Kalfarentzos F. Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant. 2009; 24: 3732-3738.
41. Hoy WE, Bertram JF, Denton RD, Zimanyi M, Samuel T, Hughson MD. Nephron number, glomerular volume, renal disease and hypertension. Curr Opin Nephrol Hypertens. 2008; 17: 258-265.
42. Hughson MD, Hoy WE, Douglas-Denton RN, Zimanyi MA, Bertram JF. Towards a definition of glomerulomegaly: clinical-pathological and methodological considerations. Nephrol Dial Transplant. 2011; 26: 2202-2208.
43. Tsuboi N, Kawamura T, Koike K, Okonogi H, Hirano K, Hamaguchi A, Miyazaki Y, Ogura M, Joh K, Utsunomiya Y, Hosoya T. Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy. Clin J Am Soc Nephrol. 2010; 5: 39-44.